Bills · S. 5736 · Text
Introduced in Senate
Confirmed from the official record
Our copy of the file on govinfo.gov, saved November 21, 2026. Fingerprint (SHA-256): 4b213a2ea21b31f5.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 5736 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
2d Session
S. 5736
To amend the Agricultural Marketing Act of 1946 to modify the
definition of the term ``hemp'', and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
November 17, 2026
Mr. Sheehy (for himself and Ms. Klobuchar) introduced the following
bill; which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To amend the Agricultural Marketing Act of 1946 to modify the
definition of the term ``hemp'', and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Hemp Guardrails Act''.
SEC. 2. HEMP.
(a) Definition of Hemp.--
(1) In general.--Section 297A(1) of the Agricultural
Marketing Act of 1946 (7 U.S.C. 1639o(1)) (as amended by
section 781 of the Agriculture, Rural Development, Food and
Drug Administration, and Related Agency Appropriations Act,
2026 (7 U.S.C. 1639o note; Public Law 119-37)), is amended--
(A) in subparagraph (A), by striking ``0.3'' and
inserting ``1.0'';
(B) in subparagraph (C)--
(i) in clause (i)--
(I) by striking ``0.3'' and
inserting ``1.0''; and
(II) by striking ``or'' after the
semicolon;
(ii) in clause (ii)--
(I) by striking subclauses (II) and
(III); and
(II) by striking ``containing--''
and all that follows through
``cannabinoids'' in subclause (I) and
inserting ``containing cannabinoids'';
and
(iii) in clause (iv)--
(I) in subclause (I), by adding
``or'' after the semicolon at the end;
and
(II) by striking subclauses (II)
and (III) and inserting the following:
``(II) more than trace amounts of
restricted cannabinoids.''; and
(C) by adding at the end the following:
``(D) Restricted cannabinoids.--For purposes of
subparagraph (C)(iv), the term `restricted
cannabinoids'--
``(i) means cannabinoids, other than delta-
9 tetrahydrocannabinol, that produce
intoxication or impairment in humans through
agonism of the cannabinoid CB1 receptor,
including delta-8 tetrahydrocannabinol, delta-
10 tetrahydrocannabinol, hexahydrocannabinol
(HHC), and tetrahydrocannabinol acetate (THC-O-
acetate), together with their isomers, analogs,
esters, ethers, and salts; and
``(ii) does not include cannabidiol (CBD),
cannabinol (CBN), cannabigerol (CBG),
cannabichromene (CBC), cannabidivarin (CBDV),
tetrahydrocannabivarin (THCV), or delta-9
tetrahydrocannabinol.
``(E) Unfinished hemp-cannabinoid ingredients.--
Notwithstanding any other provision of this paragraph,
an unfinished hemp-cannabinoid ingredient (as defined
in section 201 of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 321)) shall be considered hemp under
this subtitle.''.
(2) Technical and conforming amendments.--
(A) State and tribal plans.--Section 297B of the
Agricultural Marketing Act of 1946 (7 U.S.C. 1639p) is
amended--
(i) in subsection (a)(2)(A)(ii), by
striking ``delta-9 tetrahydrocannabinol
concentration'' and inserting ``total
tetrahydrocannabinols concentration (including
tetrahydrocannabinolic acid)''; and
(ii) in subsection (e)(2)(A)(iii), by
striking ``delta-9 tetrahydrocannabinol
concentration of more than 0.3 percent'' and
inserting ``total tetrahydrocannabinols
concentration (including tetrahydrocannabinolic
acid) of more than 1.0 percent''.
(B) Department of agriculture plan.--Section
297C(a)(2)(B) of the Agricultural Marketing Act of 1946
(7 U.S.C. 1639q(a)(2)(B)) is amended by striking
``delta-9 tetrahydrocannabinol concentration'' and
inserting ``total tetrahydrocannabinols concentration
(including tetrahydrocannabinolic acid)''.
(b) Amendments to the Federal Food, Drug, and Cosmetic Act.--
(1) Definitions.--Section 201 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 321) is amended--
(A) in paragraph (s), in the matter preceding
subparagraph (1), by striking ``food (including any
substance'' and inserting ``food (including industrial
hemp intended for human or animal use and hemp seed,
hemp seed oil, or hempseed protein not containing
cannabinoids, any substance'';
(B) in paragraph (rr), by adding at the end the
following:
``(6) The term `tobacco product' does not include a hemp-derived
cannabinoid product.''; and
(C) by adding at the end the following:
``(tt) The term `hemp-derived cannabinoid product'--
``(1) except as otherwise provided in subparagraph (2), has
the meaning given the term in section 297A of the Agricultural
Marketing Act of 1946;
``(2) may include an intermediate hemp-derived cannabinoid
product (as defined in section 297A of the Agricultural
Marketing Act of 1946) only in such cases as the Secretary
determines appropriate;
``(3) includes a hemp-derived cannabinoid dietary
supplement;
``(4) may include ingestibles, beverages, oral tinctures
and sublinguals, capsules and tablets, inhalables (other than
raw floral hemp material, smokable hemp flower, or pre-roll
material that is intended for inhalation), and topicals and
transdermals; and
``(5) does not include--
``(A) a drug that is subject to the requirements of
chapter V or section 351 of the Public Health Service
Act;
``(B) a device that is subject to the requirements
of chapter V; or
``(C) an unfinished hemp-cannabinoid ingredient.
``(uu) The term `hemp-derived cannabinoid dietary supplement'--
``(1) means a dietary supplement that--
``(A) contains one or more ingredients that are
derived from hemp;
``(B) contains one or more cannabinoids; and
``(C) is for ingestion in tablet, capsule, softgel,
gelcap, powder, gummy, chew, lozenge, tincture, oil,
spray, strip, or liquid form;
``(2) is not marketed for its impairing effects; and
``(3) does not include--
``(A) any product for inhalation, application to
the skin, or transdermal absorption;
``(B) any product containing raw floral hemp
material, an unfinished hemp-cannabinoid ingredient, or
work-in-process materials;
``(C) any product containing industrial hemp;
``(D) any product containing hemp seed, hemp seed
oil, or hempseed protein not containing cannabinoids;
or
``(E) any product containing any cannabinoid not
found in, or capable of being produced in, the hemp
plant.
``(vv) The term `hemp' has the meaning given such term in section
297A of the Agricultural Marketing Act of 1946.
``(ww) The term `unfinished hemp-cannabinoid ingredient' means an
oil, extract, concentrate, distillate, or other intermediate substance
that--
``(1) meets the criteria specified in subparagraphs (A)
through (D) of section 297A(1) of the Agricultural Marketing
Act of 1946 to be considered hemp, except that such substance
may contain a concentration of total tetrayhdrocannabinol that
exceeds 1 percent during processing, on the conditions that
such substance--
``(A) remains exclusively with actors or entities
lawfully permitted to manufacture hemp-derived
cannabinoid products under this Act; and
``(B) is not offered for retail sale;
``(2) is not for consumer use;
``(3) is not marketed, sold, distributed, or shipped to any
actors or entities other than actors or entities lawfully
permitted to manufacture hemp-derived cannabinoid products
under this Act;
``(4) is not a finished hemp product; and
``(5) is produced solely for incorporation into a finished
cannabinoid product through further processing.''.
(2) Prohibited acts.--Section 301 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 331) is amended--
(A) by inserting ``hemp-derived cannabinoid
product,'' after ``tobacco product,'' each place it
appears in paragraphs (a), (b), (c), (g), (h), and (k);
(B) in paragraph (p)--
(i) by striking ``510 or 905'' and
inserting ``510, 905, or 1103''; and
(ii) by striking ``or 905(j)'' and
inserting ``905(j), or 1103''; and
(C) by adding at the end the following:
``(jjj)(1) The introduction or delivery for introduction into
interstate commerce of any food to which has been added a hemp-derived
cannabinoid product, unless the finished product complies with the
requirements for food under chapter IV and for hemp-derived cannabinoid
products under chapter XI.
``(2) The introduction or delivery for introduction into interstate
commerce of a hemp-derived cannabinoid product that is not derived
exclusively from hemp cultivated in the United States, processed within
the United States, and finished, packaged, and labeled within the
United States.
``(3) The sale of a hemp-derived cannabinoid product to any person
younger than 21 years of age.
``(4) The possession or consumption of a hemp-derived cannabinoid
product by any person younger than 21 years of age.
``(5) The sale of a hemp-derived cannabinoid product that does not
comply with the child-resistant packaging requirements established by
regulations promulgated under section 1103.
``(6) The introduction or delivery for introduction into interstate
commerce of a hemp-derived cannabinoid product intended for human
consumption that contains, or purports to contain, raw floral hemp
material, smokable flower, or pre-roll material that is intended for
inhalation.''.
(3) Regulation of hemp-derived cannabinoid products.--The
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is
amended by adding at the end the following:
``CHAPTER XI--HEMP-DERIVED CANNABINOID PRODUCTS
``SEC. 1101. MISBRANDING.
``A hemp-derived cannabinoid product shall be deemed to be
misbranded if--
``(1) its advertising or promotion is false or misleading
in any particular;
``(2) its labeling does not bear adequate directions for
use, or adequate warnings against use by children, that are
necessary for the protection of users, or conform to such other
requirements in all respects as may be prescribed by the
Secretary;
``(3) it is in package form for use by humans, and it
contains product packaging features imitating images popularly
used to advertise to children or otherwise market to anyone
under 21 years of age, as determined by the Secretary; or
``(4) it fails to comply with any applicable requirement
established under section 1103(1).
``SEC. 1102. ADULTERATION.
``A hemp-derived cannabinoid product shall be deemed to be
adulterated if it fails to comply with any applicable requirement
established under paragraph (2) or (3) of section 1103.
``SEC. 1103. HEMP-DERIVED CANNABINOID PRODUCT STANDARDS.
``Not later than 180 days after the date of enactment of this
chapter, the Secretary shall establish, by regulation--
``(1) packaging and labeling requirements for hemp-derived
cannabinoid products, which shall include--
``(A) child-resistant packaging requirements, which
may vary based on the form, characteristics, and
intended use of the hemp-derived cannabinoid product;
and
``(B) requirements that final hemp-derived
cannabinoid products bear a label containing a quick
response (QR) code, any other scannable mechanism, or
internet address that leads to a web page with testing
results for the cannabinoid hemp product in the form of
a certificate of analysis;
``(2) uniform manufacturing and testing requirements for
hemp-derived cannabinoid products to ensure safety of such
products, which shall include--
``(A) manufacturing and testing requirements for
key components, potential contaminants, and cannabinoid
content;
``(B) requirements for third-party laboratory
testing of finished products; and
``(C) good manufacturing practice requirements for
facilities producing hemp-derived cannabinoid products;
``(3) requirements for the identification, evaluation, and
control of added substances in hemp-derived cannabinoid
products;
``(4) requirements for the recall and removal from commerce
of hemp-derived cannabinoid products that are adulterated,
misbranded, or otherwise fail to comply with applicable safety
requirements that may be prescribed by the Secretary; and
``(5) registration and recordkeeping requirements for
facilities engaged in manufacturing, processing, packing, or
holding of hemp-derived cannabinoid products intended for
distribution in the United States.
``SEC. 1104. DIETARY SUPPLEMENTS CONTAINING CANNABINOIDS.
``(a) In General.--A dietary supplement that is a hemp-derived
cannabinoid product shall comply with all applicable requirements for
dietary supplements and food under chapter IV and all applicable
requirements for hemp-derived cannabinoid products under this chapter.
``(b) Effect.--A dietary supplement that is also a hemp-derived
cannabinoid product shall not be--
``(1) deemed adulterated under section 402(f) solely on
account of constituents made or derived from cannabinoids; or
``(2) excluded from the definition of dietary supplement
under section 201(ff)(3) solely on account of constituents made
or derived from cannabis.''.
(4) Seizure.--Section 304(a)(2) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 334) is amended by striking the
period at the end and adding the following: ``Any adulterated
or misbranded hemp-derived cannabinoid product.''.
(5) Food additives.--Section 409(a) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 348(a)) is amended by adding
at the end of the matter following paragraph (3) the following:
``A food bearing or containing a hemp-derived cannabinoid
product that meets the requirements of chapter XI shall not, by
reason of bearing or containing such a hemp-derived cannabinoid
product, be considered adulterated under subparagraph (1) or
(2)(C)(i) of section 402(a).''.
(6) Inspection.--Section 704(a)(1) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 374(a)(1)) is amended, in the
first sentence, in subparagraph (A), by inserting ``hemp-
derived cannabinoid products,'' after ``tobacco products,''
each place it appears.
(7) Publicity.--Section 705(b) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 375(b)) is amended by inserting
``hemp-derived cannabinoid products,'' after ``tobacco
products,''.
(8) Presumption.--Section 709 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 379a) is amended by inserting
``hemp-derived cannabinoid product,'' after ``tobacco
product,''.
(9) Rule of construction.--Nothing in this section shall be
construed to alter, limit, supersede, or terminate the
authority of the Secretary--
(A) to administer the Substance Access Beneficiary
Engagement Incentive or any successor program under the
Centers for Medicare & Medicaid Services involving
hemp-derived cannabinoid dietary supplements (as
defined in section 201(uu) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 321(uu))); or
(B) permit coverage of a hemp-derived cannabinoid
dietary supplement (as so defined) as a supplemental
benefit under section 1852(a)(3)(D) of the Social
Security Act (42 U.S.C. 1395w-22(a)(3)(D)).
(c) Protection of State Regulatory Authority and Interstate
Commerce.--
(1) Preservation of state rights.--Except as provided in
paragraph (2), nothing in this section or the amendments made
by this section shall be construed to preempt or limit the
authority of a State, territory, or Indian Tribe to enact or
enforce laws and regulations governing the production,
manufacture, distribution, importation, or sale of hemp or
hemp-derived cannabinoid products within the borders, or
exportation out of the borders, of such State, territory, or
Indian Tribe that are more stringent than, or at least as
protective as, the standards in this section and the amendments
made by this section.
(2) Non-interference with interstate commerce.--Pursuant to
clause 3 of section 8 of Article I, United States Constitution,
no State, territory, or Indian Tribe may enact or enforce any
law that prevents the passage and delivery of a hemp-derived
cannabinoid product through the borders of such State,
territory, or Indian Tribe if such product complies with this
section and the amendments made by this section.
(3) Definitions.--In this subsection, the terms ``hemp''
and ``hemp-derived cannabinoid product'' have the meanings
given the terms in section 297A of the Agricultural Marketing
Act of 1946 (7 U.S.C. 1639o), as amended by subsection (a).
(d) Effective Date.--This section and the amendments made by this
section shall take effect on December 11, 2026.
<all>